Gastrointestinal Therapy Agents Use 2

Project Title Gastrointestinal Therapy Agents Use 2
Date Posted
Tuesday, September 23, 2014
Project ID
msy4_str073, msy4_str078
In progress

Summary table assessments of the incident and prevalent use of eleven gastrointestinal therapy agents, aprepitant, fosaprepitant dimeglumine, cimetidine, dexlansoprazole, dicyclomine HCL, lubiprostone, mesalamine, nizatidine, sucralfate, and lansoprazol. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table.  Summary tables are precompiled stratified counts.  Queries were executed in 8/19/2013. This report includes data from 16 Data Partners.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
gastrointestinal therapy agent
Time Period
2000 - 2012
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
Scroll to Top